Research & Development
‘Good’ cholesterol worse for some adults: NIH study
In the study, lower levels of "good" cholesterol were associated with increased risks for heart attacks for white but not Black adults.
November 23, 2022
Physician, medical office to pay more than $2.6M involving clinical lab kickbacks
Feel Well Health and its owner violated the Anti-Kickback Statute by receiving remuneration from Boston Heart Diagnostics for clinical laboratory services for Medicare patients, according to the DOJ.
November 15, 2022
UK Biobank study links COVID-19 infection with poor cardiovascular health
Individuals who have been hospitalized because of COVID-19 infection have a higher risk of experiencing adverse cardiovascular health outcomes, according to a UK Biobank study.
October 27, 2022
QuidelOrtho to invest 750K in heart disease awareness
As part of the collaboration, Quidel will invest the funding and give support for campaigns and initiatives led by the AHA's San Diego division.
June 21, 2022
Study to use genetic testing to evaluate heart disease
Researchers from Dignity Health's Chandler Regional Medical Center, Mercy Gilbert Medical Center, and St. Joseph's Hospital and Medical Center will gather approximately 2,000 DNA samples from men and women between the ages of 40 and 60 with no known history of heart disease. The samples will be analyzed for genetic markers known to cause heart disease at Baylor College of Medicine's Human Genome Sequencing Center Clinical Lab in Houston.
February 22, 2022
Cardio Diagnostics debuts coronary heart disease test
Primary care clinicians currently use two tools -- the Framingham Risk Score (FRS) and the Atherosclerotic Cardiovascular Disease (ASCVD) Risk Calculator -- for predicting future heart disease but both have low sensitivity, according to Cardio Diagnostics.
January 28, 2021
Chembio Diagnostics applies for FDA CLIA waiver for HIV, syphilis test
Dr. Fauci invokes Yogi Berra to describe emerging infectious disease challenge
Thermo Fisher Scientific introduces digital PCR liquid-biopsy assays for academic, clinical research
Thermo Fisher Scientific updates Applied Biosystems genetic analyzers to comply with IVDR
Week in Review: Elizabeth Holmes sentenced; good cholesterol worse for some adults; earlier type 2 diabetes diagnosis; and more
Quest Diagnostics completes acquisition of Summa Health outreach lab services business
Fujifilm Medical to add IVD to portfolio
Fujifilm Wako Diagnostics has developed biomarkers that assess the risk of hepatocellular carcinoma in patients with chronic liver disease, as well as IVD reagents for disorders of lipid metabolism, lupus, rheumatoid arthritis, coronary heart disease, and diabetes, according to Fujifilm Medical Systems.
August 16, 2020
Heart association offers advice on who should get genetic testing
Published on July 13 in Circulation: Genomic and Precision Medicine, the statement provides information on what the scientific community does and doesn't know about genes and genetic combinations that may influence heritable heart disease risk.
July 23, 2020
Week in Review: Coronavirus stool samples under scrutiny | Testing company accused of fraud | Genetic risk scoring in heart disease
Dear LabPulse Member,
June 11, 2020
Who stands to gain from polygenic risk scoring for heart disease?
The retrospective study evaluated the value of polygenic risk scores (PRSs) in a total of 47,108 middle-aged people (mean, 60 years) treated at hospitals affiliated with three different U.S. institutions on the East Coast: Partners HealthCare (MA), the University of Pennsylvania Health System (PA), and the Mount Sinai Health System (NY).
June 9, 2020
American College of Cardiology paves way for return of diagnostics
The pandemic has restricted routine medical care, including invasive procedures to treat heart disease and diagnostic tests to diagnose it, the ACC said. Delays in this care can increase patients' risk of adverse outcomes, according to the college.
May 4, 2020
Could a 5th 'vital sign' curb the spread of COVID-19?
A typical patient evaluation includes an assessment of temperature, heart rate, respiratory rate, and blood pressure. But in the context of COVID-19, adding travel history is key, wrote a research pair led by Dr. Trish Perl, chief of the division of infectious diseases at the University of Texas Southwestern Medical Center.
March 2, 2020
Page 1 of 2